B

Biotoxtech Co Ltd
KOSDAQ:086040

Watchlist Manager
Biotoxtech Co Ltd
KOSDAQ:086040
Watchlist
Price: 2 830 KRW -0.35% Market Closed
Market Cap: 45.2B KRW

Net Margin
Biotoxtech Co Ltd

-13.4%
Current
-6%
Average
1.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-13.4%
=
Net Income
-5.8B
/
Revenue
43.4B

Net Margin Across Competitors

No Stocks Found

Biotoxtech Co Ltd
Glance View

Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2007-09-21. The firm provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.

Intrinsic Value
3 758.41 KRW
Undervaluation 25%
Intrinsic Value
Price
B
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-13.4%
=
Net Income
-5.8B
/
Revenue
43.4B
What is the Net Margin of Biotoxtech Co Ltd?

Based on Biotoxtech Co Ltd's most recent financial statements, the company has Net Margin of -13.4%.

Back to Top